tiprankstipranks
Advertisement
Advertisement

HAE Stock Latest News

Haemonetics (HAE) Q4 Earnings Cheat Sheet
Pre-EarningsHaemonetics (HAE) Q4 Earnings Cheat Sheet
10h ago
HAE
Haemonetics Announces Upcoming Departure of Longtime Board Director
PremiumCompany Announcements
Haemonetics Announces Upcoming Departure of Longtime Board Director
4d ago
8K
HAE
Haemonetics price target lowered to $70 from $80 at Mizuho
PremiumThe Fly
Haemonetics price target lowered to $70 from $80 at Mizuho
22d ago
HAE
Haemonetics price target lowered to $84 from $88 at BTIG
PremiumThe Fly
Haemonetics price target lowered to $84 from $88 at BTIG
22d ago
HAE
Haemonetics price target lowered to $64 from $70 at Citi
PremiumThe Fly
Haemonetics price target lowered to $64 from $70 at Citi
28d ago
HAE
Haemonetics: FDA Label Expansion and New Product Launches Poised to Reignite Vascular Closure Growth by FY27
PremiumRatingsHaemonetics: FDA Label Expansion and New Product Launches Poised to Reignite Vascular Closure Growth by FY27
1M ago
HAE
Haemonetics: FDA approves expanded labeling for VASCADE MVP XL system
Premium
The Fly
Haemonetics: FDA approves expanded labeling for VASCADE MVP XL system
1M ago
HAE
Haemonetics price target lowered to $70 from $75 at Citi
Premium
The Fly
Haemonetics price target lowered to $70 from $75 at Citi
2M ago
HAE
Haemonetics Retires 2026 Convertible Notes, Simplifies Capital Structure
PremiumCompany Announcements
Haemonetics Retires 2026 Convertible Notes, Simplifies Capital Structure
2M ago
8K
HAE
Haemonetics receives FDA clearance for NexSys PCS Plasma Collection System
PremiumThe Fly
Haemonetics receives FDA clearance for NexSys PCS Plasma Collection System
2M ago
HAE
Haemonetics Releases 2024-2025 Corporate Responsibility Report
PremiumCompany Announcements
Haemonetics Releases 2024-2025 Corporate Responsibility Report
3M ago
8K
HAE
Haemonetics Earnings Call: Strong Core, IVT Drag
PremiumCompany Announcements
Haemonetics Earnings Call: Strong Core, IVT Drag
3M ago
HAE
Haemonetics price target lowered to $81 from $99 at Baird
PremiumThe FlyHaemonetics price target lowered to $81 from $99 at Baird
3M ago
HAE
Haemonetics price target lowered to $80 from $90 at Mizuho
Premium
The Fly
Haemonetics price target lowered to $80 from $90 at Mizuho
3M ago
HAE
Haemonetics price target raised to $94 from $93 at Barrington
Premium
The Fly
Haemonetics price target raised to $94 from $93 at Barrington
3M ago
HAE
Haemonetics price target lowered to $75 from $88 at Citi
PremiumThe Fly
Haemonetics price target lowered to $75 from $88 at Citi
3M ago
HAE
Haemonetics reports Q3 adjusted EPS $1.31, consensus $1.25
PremiumThe Fly
Haemonetics reports Q3 adjusted EPS $1.31, consensus $1.25
3M ago
HAE
Haemonetics narrows FY26 adjusted EPS view to $4.90-$5.00 from $4.80-$5.00
PremiumThe Fly
Haemonetics narrows FY26 adjusted EPS view to $4.90-$5.00 from $4.80-$5.00
3M ago
HAE
HAE Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
HAE Upcoming Earnings Report: What to Expect?
3M ago
HAE
Balancing Plasma Strength Against Vascular Closure Uncertainty: Maintaining a Neutral (Hold) View on Haemonetics
PremiumRatingsBalancing Plasma Strength Against Vascular Closure Uncertainty: Maintaining a Neutral (Hold) View on Haemonetics
3M ago
HAE
Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition
Premium
The Fly
Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition
4M ago
HAE
OBIO
Haemonetics price target raised to $93 from $90 at Barrington
Premium
The Fly
Haemonetics price target raised to $93 from $90 at Barrington
4M ago
HAE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >